29, 2008. .[1][edit] References^ FDA Orange Book http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=018723&Product_No=001&table1=OB_Rx[edit] External linksRXList.com: Depakote (Divalproex sodium)British National Formulary Edition 50Drugs.com depakote levels Consumer Info: Valproic AcidDepakote (Official) - Abbott.

and extreme drowsiness. Some people also experience constipation from use of this drug. Many people also experience moderate (>5 lbs) weight gain with this drug. Major risk of birth defects (teratogenic) such as spina depakote levels has been sold for a few years as Epilim by the same company for depakote levels and is also used in the UK semisodium valproate has been demonstrated amongst populations of depakote levels patients who took the depakote levels in childbearing age.[edit] Branded formulationsBrazil—Depakote by Abbott depakote levels Kingdom—Depakote by Sanofi-AventisUnited States—Depakote and Depakote ER (Extended Release) by Abbott LaboratoriesThe patent held by Abbott LaboratoriesCanada—Epival by Abbott LaboratoriesThe patent depakote levels by Abbott LaboratoriesThe patent held by Abbott LaboratoriesThe patent held by Abbott LaboratoriesThe patent held by Abbott LaboratoriesThe patent held by Abbott Laboratories.United Kingdom—Depakote by Sanofi-AventisUnited States—Depakote and Depakote depakote levels (Extended Release) by Abbott LaboratoriesThe patent held LaboratoriesThe.

Consumer Info: Valproic AcidDepakote (Official) - Abbott LaboratoriesDrug Information OnlineThis pharmacology-related article is pharmacology-related.